AstraZeneca and Daiichi’s Datroway Boosts Overall Survival in Breast Cancer Trial

AstraZeneca and Daiichi Sankyo’s precision drug Datroway improved survival prospects in patients with an advanced form of breast cancer in a late-stage trial, the drugmakers…

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/astrazeneca-and-daiichis-datroway-boosts-overall-survival-2025a1000qqc
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started